{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:24:14Z","timestamp":1782757454327,"version":"3.54.5"},"reference-count":40,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2016.0213","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:27:14Z","timestamp":1525253234000},"source":"Crossref","is-referenced-by-count":10,"title":["Dependence on Prescription Opioids: Prevention, Diagnosis and Treatment"],"prefix":"10.3238","author":[{"given":"Johannes","family":"Just","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"M\u00fccke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Bleckwenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2016,4,1]]},"reference":[{"key":"10.3238\/arztebl.2016.0213_ref1","unstructured":"Bundes\u00e4rztekammer: Medikamente \u2013 sch\u00e4dlicher Gebrauch und Abh\u00e4ngigkeit. Leitfaden f\u00fcr die \u00e4rztliche Praxis K\u00f6ln: Deutscher \u00c4rzte-Verlag 2007."},{"key":"10.3238\/arztebl.2016.0213_ref2","doi-asserted-by":"crossref","unstructured":"Schubert I, Ihle P, Sabatowski R: Increase in opiate prescription in Germany between 2000 and 2010\u2014a study based on insurance data. Dtsch Arztebl Int 2013; 110: 45\u201351","DOI":"10.3238\/arztebl.2013.0045"},{"key":"10.3238\/arztebl.2016.0213_ref3","doi-asserted-by":"crossref","unstructured":"Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL: Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med 2011; 12: 657\u201367","DOI":"10.1111\/j.1526-4637.2011.01075.x"},{"key":"10.3238\/arztebl.2016.0213_ref4","doi-asserted-by":"crossref","unstructured":"Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN: Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015; 156: 569\u201376","DOI":"10.1097\/01.j.pain.0000460357.01998.f1"},{"key":"10.3238\/arztebl.2016.0213_ref5","unstructured":"Marschall U, L\u2019hoest H: Opioidtherapie in der Versorgungsrealit\u00e4t. Ein Beitrag zur Diskussion um ein weitverbreitetes Arzneimittel. BARMER GEK Gesundheitswesen aktuell 2011: 242\u201369."},{"key":"10.3238\/arztebl.2016.0213_ref6","doi-asserted-by":"crossref","unstructured":"Hoffmann F, Glaeske G, Windt R: Verordnung von starken Opioiden im Jahr 2011. Der Schmerz 2012; 26: 707\u201314","DOI":"10.1007\/s00482-012-1240-7"},{"key":"10.3238\/arztebl.2016.0213_ref7","doi-asserted-by":"crossref","unstructured":"Pflughaupt M, Scharnagel R, Gossrau G, Kaiser U, Koch T, Sabatowski R: [Physicians' knowledge and attitudes concerning the use of opioids in the treatment of chronic cancer and non-cancer pain]. Schmerz 2010; 24: 267\u201375","DOI":"10.1007\/s00482-010-0913-3"},{"key":"10.3238\/arztebl.2016.0213_ref8","unstructured":"Substance Abuse and Mental Health Service Administration: Prescription drug misuse and abuse. www.samhsa.gov\/prescription-drug-misuse-abuse (last accessed on 13 November 2015)."},{"key":"10.3238\/arztebl.2016.0213_ref9","doi-asserted-by":"crossref","unstructured":"Radbruch L, Glaeske G, Grond S, et al.: Topical review on the abuse and miisuse potential of Tramadol and Tilidine in Germany. Subst Abus 2013; 34: 313\u201320","DOI":"10.1080\/08897077.2012.735216"},{"key":"10.3238\/arztebl.2016.0213_ref10","unstructured":"Leitlinie A: Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen \u2013 \u201cLONTS\u201d www.awmf.org\/leitlinien\/detail\/ll\/145\u2013003.html (last accessed on 30 May 2015)."},{"key":"10.3238\/arztebl.2016.0213_ref11","doi-asserted-by":"crossref","unstructured":"H\u00e4user W, Bock F, Engeser P, T\u00f6lle T, Willweber-Strumpf A, Petzke F: Clinical practice guideline: Long-term opioid use in non-cancer pain. Dtsch Arztebl Int 2014; 111: 732\u201340","DOI":"10.3238\/arztebl.2014.0732"},{"key":"10.3238\/arztebl.2016.0213_ref12","doi-asserted-by":"crossref","unstructured":"Bennett RM, Kamin M, Karim R, Rosenthal N: Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study. JAMA 2003; 114: 537\u201345","DOI":"10.1016\/S0002-9343(03)00116-5"},{"key":"10.3238\/arztebl.2016.0213_ref13","doi-asserted-by":"crossref","unstructured":"Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE: Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care 2011; 39: 804\u201323","DOI":"10.1177\/0310057X1103900505"},{"key":"10.3238\/arztebl.2016.0213_ref14","doi-asserted-by":"crossref","unstructured":"Turk DC, Swanson KS, Gatchel RJ: Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008; 24: 497\u2013508","DOI":"10.1097\/AJP.0b013e31816b1070"},{"key":"10.3238\/arztebl.2016.0213_ref15","doi-asserted-by":"crossref","unstructured":"Edlund MJ, Martin BC, Fan MY, Devries A, Braden JB, Sullivan MD: Risks for opioid abuse and dependence among recipients of chronic opioid therapy: Results from the TROUP Study. Drug Alcohol Depend 2010; 112: 90\u20138","DOI":"10.1016\/j.drugalcdep.2010.05.017"},{"key":"10.3238\/arztebl.2016.0213_ref16","unstructured":"Kahan M, Srivastava A, Wilson L, Gourlay D, Midmer D: Misuse of and dependence on opioids: study of chronic pain patients. Can Fam Physician 2006; 52: 1081\u20137"},{"key":"10.3238\/arztebl.2016.0213_ref17","doi-asserted-by":"crossref","unstructured":"Franklin GM, Mai J, Turner J, Sullivan M, Wickizer T, Fulton-Kehoe D: Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline. Am J Ind Med 2012; 55: 325\u201331","DOI":"10.1002\/ajim.21998"},{"key":"10.3238\/arztebl.2016.0213_ref18","doi-asserted-by":"crossref","unstructured":"Passik SD, Kirsh KL, McDonald MV, et al.: A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J Pain Symptom Manage 2000; 19: 274\u201386","DOI":"10.1016\/S0885-3924(00)00119-6"},{"key":"10.3238\/arztebl.2016.0213_ref19","doi-asserted-by":"crossref","unstructured":"Ziegler PP: Addiction and the treatment of pain. Subst Use Misuse 2005; 40: 1945\u201354","DOI":"10.1080\/10826080500294841"},{"key":"10.3238\/arztebl.2016.0213_ref20","unstructured":"Peck SB, Gilchrist J, Clemans-Taylor L: Clinical inquiry: is there a primary care tool to detect aberrant drug-related behaviors in patients on opioids? J Fam Pract 2014; 63: 162\u20134"},{"key":"10.3238\/arztebl.2016.0213_ref21","doi-asserted-by":"crossref","unstructured":"Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK: Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10: 131\u201346","DOI":"10.1016\/j.jpain.2008.10.009"},{"key":"10.3238\/arztebl.2016.0213_ref22","doi-asserted-by":"crossref","unstructured":"Milone MC: Laboratory testing for prescription opioids. J Med Toxicol 2012; 8: 408\u201316","DOI":"10.1007\/s13181-012-0274-7"},{"key":"10.3238\/arztebl.2016.0213_ref23","unstructured":"Bundes\u00e4rztekammer: Mitteilungen: Hintergr\u00fcnde und Inhalte der Richtlinien-Novelle substitutionsgest\u00fctzte Behandlung Opiatabh\u00e4ngiger. Dtsch Arztebl 2010; 107: A-511"},{"key":"10.3238\/arztebl.2016.0213_ref24","doi-asserted-by":"crossref","unstructured":"Amato L, Minozzi S, Davoli M, Vecchi S, Ferri MM, Mayet S: Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification. Database Syst Rev 2008: CD005031.","DOI":"10.1002\/14651858.CD005031.pub3"},{"key":"10.3238\/arztebl.2016.0213_ref25","unstructured":"Braun B: Jahresbericht der deutschen Suchthilfestatistik (DSHS) www.suchthilfestatistik.de\/cms\/images\/dshs_jahresbericht_2014.pdf (last accessed on 19 November 2015)."},{"key":"10.3238\/arztebl.2016.0213_ref26","doi-asserted-by":"crossref","unstructured":"Streltzer J, Linden M: Erh\u00f6hte Schmerzempfindlichkeit unter Dauerbehandlung mit Opiaten. Nervenarzt 2008; 79: 607\u201311","DOI":"10.1007\/s00115-008-2454-x"},{"key":"10.3238\/arztebl.2016.0213_ref27","doi-asserted-by":"crossref","unstructured":"Rome JD, Townsend CO, Bruce BK, Sletten CD, Luedtke CA, Hodgson JE: Chronic noncancer pain rehabilitation with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Mayo Clinic Proceedings 2004; 79: 759\u201368","DOI":"10.4065\/79.6.759"},{"key":"10.3238\/arztebl.2016.0213_ref28","doi-asserted-by":"crossref","unstructured":"Freye E: Opioide in der Medizin. Heidelberg: Springer-Verlag; 2009.","DOI":"10.1007\/978-3-540-88797-3_26"},{"key":"10.3238\/arztebl.2016.0213_ref29","doi-asserted-by":"crossref","unstructured":"Mendelson J, Flower K, Pletcher MJ, Galloway GP: Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine. Exp Clin Psychopharmacol 2008; 16: 435\u201341","DOI":"10.1037\/a0013637"},{"key":"10.3238\/arztebl.2016.0213_ref30","unstructured":"BfArM: Bericht zum Substitutionsregister. www.bfarm.de\/DE\/Bundesopiumstelle\/SubstitReg\/Subst_Bericht\/_node.html (last accessed on 15 January 2015)."},{"key":"10.3238\/arztebl.2016.0213_ref31","doi-asserted-by":"crossref","unstructured":"Walsh SL, Eissenberg T: The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend 2003; 70: 13\u201327","DOI":"10.1016\/S0376-8716(03)00056-5"},{"key":"10.3238\/arztebl.2016.0213_ref32","doi-asserted-by":"crossref","unstructured":"Davids E, Gastpar M: Buprenorphine in the treatment of opioid dependence. Eur Neuropsychopharmacol 2004; 14: 209\u201316","DOI":"10.1016\/S0924-977X(03)00146-9"},{"key":"10.3238\/arztebl.2016.0213_ref33","doi-asserted-by":"crossref","unstructured":"Weiss RD, Potter JS, Fiellin DA, et al.: Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomizedcontrolled trial. Arch Gen Psychiatry 2011; 68: 1238\u201346","DOI":"10.1001\/archgenpsychiatry.2011.121"},{"key":"10.3238\/arztebl.2016.0213_ref34","doi-asserted-by":"crossref","unstructured":"Fiellin DA, Schottenfeld RS, Cutter CJ, Moore BA, Barry DT, O'Connor PG: Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial. JAMA 2014; 174: 1947\u201354","DOI":"10.1001\/jamainternmed.2014.5302"},{"key":"10.3238\/arztebl.2016.0213_ref35","doi-asserted-by":"crossref","unstructured":"McDermott KA, Griffin ML, Connery HS, et al.: Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. J Clin Psychiatry 2015; 76: 189\u201394","DOI":"10.4088\/JCP.14m09096"},{"key":"10.3238\/arztebl.2016.0213_ref36","doi-asserted-by":"crossref","unstructured":"Moore BA, Fiellin DA, Barry DT, et al.: Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med 2007; 22: 527\u201330","DOI":"10.1007\/s11606-007-0129-0"},{"key":"10.3238\/arztebl.2016.0213_ref37","doi-asserted-by":"crossref","unstructured":"Dreifuss JA, Griffin ML, Frost K, et al.: Patient characteristics associated with buprenorphine\/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend 2013; 131: 112\u20138","DOI":"10.1016\/j.drugalcdep.2012.12.010"},{"key":"10.3238\/arztebl.2016.0213_ref38","doi-asserted-by":"crossref","unstructured":"Griffin ML, Dodd DR, Potter JS, et al.: Baseline characteristics and treatment outcomes in prescription opioid dependent patients with and without co-occurring psychiatric disorder. Am J Drug Alcohol Abuse 2014; 40: 157\u201362","DOI":"10.3109\/00952990.2013.842241"},{"key":"10.3238\/arztebl.2016.0213_ref39","unstructured":"Mailis-Gagnon A, Lakha SF, Ou T, et al.: Chronic noncancer pain: characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic. Can Fam Physician 2011; 57: e97\u2013105"},{"key":"10.3238\/arztebl.2016.0213_ref40","doi-asserted-by":"crossref","unstructured":"Bickel WK, Amass L, Higgins ST, Badger GJ, Esch RA: Effects of adding behavioral treatment to opioid detoxification with buprenorphine. J Consult Clin Psychol 1997; 65: 803\u201310","DOI":"10.1037\/0022-006X.65.5.803"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T13:22:13Z","timestamp":1638796933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2016.0213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2016.0213","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}